Safety And Efficacy Of Tazemetostat, A First-In-Class Ezh2 Inhibitor, In Patients (Pts) With Epithelioid Sarcoma (Es) (Nct02601950).
Silvia Stacchiotti,Patrick Schoffski,Robin Jones,Mark Agulnik,Victor Manuel Villalobos,Thierry Marie Jahan,Tom Wei-Wu Chen,Antoine Italiano,George D. Demetri,Gregory Michael Cote,Rashmi Chugh,Steven Attia,Abha A. Gupta,Elizabeth T. Loggers,Brian Van Tine, Laura Sierra,Jay Yang, Anand Rajarethinam,Mrinal M. Gounder JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例